Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47


WaistonBelt X: A Belt-Type Wearable Device with Sensing and Intervention Toward Health Behavior Change.

Nakamura Y, Matsuda Y, Arakawa Y, Yasumoto K.

Sensors (Basel). 2019 Oct 22;19(20). pii: E4600. doi: 10.3390/s19204600.


Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.

Kishi T, Sakuma K, Nomura I, Matsuda Y, Mishima K, Iwata N.

Int J Neuropsychopharmacol. 2019 Nov 1;22(11):698-709. doi: 10.1093/ijnp/pyz040.


Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis.

Kishi T, Ikuta T, Matsuda Y, Iwata N.

Neuropsychopharmacol Rep. 2019 Sep;39(3):256-259. doi: 10.1002/npr2.12070. Epub 2019 Jul 8.


Effectiveness of high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with treatment-resistant depression: A randomized clinical trial of 37.5-minute vs 18.75-minute protocol.

Kito S, Miyazi M, Nakatani H, Matsuda Y, Yamazaki R, Okamoto T, Igarashi Y.

Neuropsychopharmacol Rep. 2019 Sep;39(3):203-208. doi: 10.1002/npr2.12066. Epub 2019 Jun 25.


Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials.

Kishi T, Ikuta T, Sakuma K, Matsuda Y, Iwata N.

J Psychiatr Res. 2019 Aug;115:121-128. doi: 10.1016/j.jpsychires.2019.05.020. Epub 2019 May 20.


Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.

Oya K, Sakuma K, Esumi S, Hashimoto Y, Hatano M, Matsuda Y, Matsui Y, Miyake N, Nomura I, Okuya M, Iwata N, Kato M, Hashimoto R, Mishima K, Watanabe N, Kishi T.

Neuropsychopharmacol Rep. 2019 Sep;39(3):241-246. doi: 10.1002/npr2.12056. Epub 2019 Apr 26.


EmoTour: Estimating Emotion and Satisfaction of Users Based on Behavioral Cues and Audiovisual Data.

Matsuda Y, Fedotov D, Takahashi Y, Arakawa Y, Yasumoto K, Minker W.

Sensors (Basel). 2018 Nov 15;18(11). pii: E3978. doi: 10.3390/s18113978.


Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials.

Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N.

Neuropsychiatr Dis Treat. 2018 Oct 1;14:2519-2530. doi: 10.2147/NDT.S176676. eCollection 2018.


Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.

Kishi T, Ikuta T, Matsui Y, Inada K, Matsuda Y, Mishima K, Iwata N.

Psychol Med. 2019 Apr;49(5):772-779. doi: 10.1017/S0033291718001393. Epub 2018 Jun 18.


Anti-dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-analysis.

Kishi T, Ikuta T, Oya K, Matsunaga S, Matsuda Y, Iwata N.

Int J Neuropsychopharmacol. 2018 May 14. doi: 10.1093/ijnp/pyy045. [Epub ahead of print]


Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Kishi T, Matsui Y, Matsuda Y, Katsuki A, Hori H, Yanagimoto H, Sanada K, Morita K, Yoshimura R, Shoji Y, Hagi K, Iwata N.

Pharmacopsychiatry. 2019 Feb;52(2):52-62. doi: 10.1055/a-0574-0088. Epub 2018 Mar 7.


A 6-Month Follow-up Case Study of Low-Frequency Right Prefrontal Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Bipolar Depression.

Kito S, Matsuda Y, Sewaki Y, Sekiya J, Fujii T, Noda T, Ikezawa S, Takano H, Nakazawa K, Nomura M, Setoyama S, Nakagome K.

J ECT. 2017 Dec;33(4):e43-e44. doi: 10.1097/YCT.0000000000000459. No abstract available.


Response to the letter from Dr. Veerman and colleagues.

Kishi T, Ikuta T, Matsuda Y, Iwata N.

Psychopharmacology (Berl). 2017 Dec;234(23-24):3537-3538. doi: 10.1007/s00213-017-4757-8. Epub 2017 Oct 7. No abstract available.


Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population.

Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N.

Neuropsychiatr Dis Treat. 2017 May 11;13:1281-1302. doi: 10.2147/NDT.S134340. eCollection 2017.


Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.

Kishi T, Matsuda Y, Iwata N.

Psychopharmacology (Berl). 2017 Jul;234(14):2113-2125. doi: 10.1007/s00213-017-4616-7. Epub 2017 May 15.


Crossover from localized to itinerant states in hydrocarbon Mott insulators.

Phan QTN, Oikawa S, Heguri S, Matsuda Y, Tanigaki K.

Dalton Trans. 2017 May 23;46(20):6715-6722. doi: 10.1039/c7dt00467b.


Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial.

Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N.

Neuropsychiatr Dis Treat. 2017 Jan 6;13:117-125. doi: 10.2147/NDT.S124898. eCollection 2017.


A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders.

Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N.

Neuropsychiatr Dis Treat. 2016 Nov 28;12:3041-3049. eCollection 2016.


A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.

Murakami T, Usui T, Nakajima A, Mochida Y, Saito S, Nambu T, Kato T, Matsuda Y, Yonemitsu S, Muro S, Oki S.

Intern Med. 2015;54(19):2475-81. doi: 10.2169/internalmedicine.54.4886. Epub 2015 Oct 1.

Supplemental Content

Loading ...
Support Center